ArticleJournal of personalized medicine2023

Spironolactone as a Potential New Treatment to Prevent Arrhythmias in Arrhythmogenic Cardiomyopathy Cell Model.

Jean-Baptiste Reisqs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.